Production of IgG and IgM autoantibody to the alternative pathway C3 convertase in normal individuals and patients with membranoproliferative glomerulonephritis
- PMID: 1697516
- DOI: 10.1016/0090-1229(90)90018-l
Production of IgG and IgM autoantibody to the alternative pathway C3 convertase in normal individuals and patients with membranoproliferative glomerulonephritis
Abstract
To understand the origin of autoantibody production, we studied the ontogeny of antibody to the alternative pathway C3 convertase (C3 nephritic factor or C3NeF). Peripheral blood mononuclear cells from newborns, normal adults, and patients with membranoproliferative glomerulonephritis produced IgM and IgG C3NeF after culture for 14 days with pokeweed mitogen. Both IgM and IgG moieties appear to have the same paratope and are able to inhibit each other's binding and function. The affinity constant for each of the C3NeF molecules was moderately high (10(8) liters/mol) and there appeared to be little difference between the Ka values for the IgG and the IgM autoantibodies or between Ka values for autoantibodies isolated from newborns, adults, and patients. These data, then, indicate that the ability to produce C3NeF autoantibody is present from the time of birth in normal individuals. The high affinity of these autoantibodies under normal conditions suggests that C3NeF may play a more important physiological role than previously anticipated.
Similar articles
-
Evidence that production of autoantibody to the alternative pathway C3 convertase is a normal physiologic event.J Pediatr. 1990 May;116(5):S103-8. doi: 10.1016/s0022-3476(05)82711-8. J Pediatr. 1990. PMID: 2329411
-
Autoantibody to the alternative pathway C3/C5 convertase and its anti-idiotypic response. A study in affinity.J Immunol. 1992 Jan 1;148(1):137-41. J Immunol. 1992. PMID: 1727863
-
Human polyclonal and monoclonal IgG and IgM complement 3 nephritic factors: evidence for idiotypic commonality.Clin Immunol Immunopathol. 1989 Oct;53(1):113-22. doi: 10.1016/0090-1229(89)90106-2. Clin Immunol Immunopathol. 1989. PMID: 2475285
-
On the origin and control of C3NeF.In Vivo. 1988 Jan-Feb;2(1):79-81. In Vivo. 1988. PMID: 2979821 Review.
-
Nephritic Factors: An Overview of Classification, Diagnostic Tools and Clinical Associations.Front Immunol. 2019 Apr 24;10:886. doi: 10.3389/fimmu.2019.00886. eCollection 2019. Front Immunol. 2019. PMID: 31068950 Free PMC article. Review.
Cited by
-
Autoimmune abnormalities of the alternative complement pathway in membranoproliferative glomerulonephritis and C3 glomerulopathy.Pediatr Nephrol. 2019 Aug;34(8):1311-1323. doi: 10.1007/s00467-018-3989-0. Epub 2018 Jun 9. Pediatr Nephrol. 2019. PMID: 29948306 Review.
-
Occurrence of C3 nephritic factor and C4 nephritic factor in membranoproliferative glomerulonephritis (MPGN).Clin Exp Immunol. 1994 Feb;95(2):316-21. doi: 10.1111/j.1365-2249.1994.tb06530.x. Clin Exp Immunol. 1994. PMID: 8306508 Free PMC article.
-
Circulating complement levels and C3 glomerulopathy.Clin J Am Soc Nephrol. 2014 Nov 7;9(11):1829-31. doi: 10.2215/CJN.09620914. Epub 2014 Oct 23. Clin J Am Soc Nephrol. 2014. PMID: 25341723 Free PMC article. No abstract available.
-
Anti-complement-factor H-associated glomerulopathies.Nat Rev Nephrol. 2016 Sep;12(9):563-78. doi: 10.1038/nrneph.2016.99. Epub 2016 Jul 25. Nat Rev Nephrol. 2016. PMID: 27452363 Review.
-
Acquired drivers of C3 glomerulopathy.Clin Kidney J. 2025 Jan 27;18(3):sfaf022. doi: 10.1093/ckj/sfaf022. eCollection 2025 Mar. Clin Kidney J. 2025. PMID: 40052168 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Miscellaneous